by ODs on Education (an ODs on Finance production)
Optometry’s most productive podcast - where you earn a half hour of CE every time you tune in, absolutely free, with hosts Dr. Aaron Neufeld & Dr. Chris Lopez.
Language
🇺🇲
Publishing Since
10/3/2024
Email Addresses
1 available
Phone Numbers
0 available
April 21, 2025
<p>(97461-PO, 0.5 hr)</p><p>In this series, Dr. Jeff Banas and Dr. Nick Bruns will walk us through the fundamentals of the light adjustable lens — what it is, how it works, and why it’s becoming a game-changer in surgical vision correction. Today’s episode sets the foundation: we’ll cover the evolution of adjustable IOLs, why traditional lenses often fall short, and how the LAL allows patients to customize their vision after surgery.</p><p>Dr. Bruns is actually one of the most experienced ODs in the country when it comes to LAL — having started with it back in early 2020 — and his insights on patient outcomes, workflow integration, and refractive accuracy are incredibly valuable.</p><p>Dr. Banas brings a fantastic perspective from both the OD and patient education side, especially when it comes to managing expectations and guiding patients through the adjustment process.</p>
March 31, 2025
<p>(96582-PM, 0.5 hr CE)</p><p>Dr. Chris Lopez discusses the complexities of billing and coding for glaucoma and retina conditions in optometry. He highlights that only 28% of optometrists bill for visual fields, 28% for OCT of the nerve, 27% for OCT of the retina, 33% for fundus photos, 6% for pachymetry, and less than 5% for gonioscopy. Ophthalmologists bill for these tests at higher rates. </p><p>Dr. Lopez emphasizes the importance of medical necessity and provides detailed reimbursement rates for various tests. He also notes the growing demand for medical eye care due to an aging population and the need for optometrists to expand their roles.</p>
March 17, 2025
<p>(96581-PH, 0.5 hr CE)</p><p>Hosted by Dr. Chris Lopez and Dr. Sam Valley, this episode discusses hydroxychloroquine, its uses, side effects, and role in eye care. </p><p>Introduced in 1955, hydroxychloroquine is used for malaria treatment, prophylaxis, and autoimmune diseases like lupus and rheumatoid arthritis. Key dosing guidelines are 400 mg weekly for malaria prophylaxis, 800 mg initially followed by 400 mg at intervals for malaria treatment, and 200-400 mg daily for autoimmune diseases. </p><p>Monitoring for toxicity involves visual field testing, OCT retina, and other assessments. Risk factors include dose, duration, age, renal function, and genetics. Effective communication with rheumatologists is crucial for patient care.</p>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.